Results 51 to 60 of about 84,576 (334)

Molecular Analysis of Prothrombotic Gene Variants in Venous Thrombosis: A Potential Role for Sex and Thrombotic Localization [PDF]

, 2020
Background: Requests to test for thrombophilia in the clinical context are often not evidence-based. Aim: To define the role of a series of prothrombotic gene variants in a large population of patients with different venous thromboembolic diseases ...
AMATO, FELICE, BRUZZESE, DARIO, CASTALDO, GIUSEPPE, CERNERA, Gustavo, COMEGNA, Marika, DI LULLO, ANTONELLA MIRIAM, DI MINNO, ALESSANDRO, ELCE, AUSILIA, LIGUORI, RENATO, ZARRILLI, FEDERICA   +9 more
core   +1 more source

Right Ventricle Remodeling in Chronic Thromboembolic Pulmonary Hypertension

Journal of Translational Internal Medicine, 2022
Chronic thromboembolic pulmonary hypertension (CTEPH) is an underdiagnosed, but potentially curable pulmonary vascular disease. The increased pulmonary vascular resistance in CTEPH is caused by unresolved proximal thrombus and secondary microvasculopathy
Jixiang Liu, Peiran Yang, Han Tian, K. Zhen, C. McCabe, Lan Zhao, Z. Zhai   +6 more
semanticscholar   +1 more source

Dynamic vascular changes in chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy

Pulmonary Circulation, 2020
Residual pulmonary hypertension is an important sequela after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Recurrent thrombosis or embolism could be a contributor to this residual pulmonary hypertension but the potential ...
Dieuwertje Ruigrok, Natalia J. Braams, Esther J. Nossent, Peter I. Bonta, Anco Boonstra, Rutger J. Lely, Frederikus A. Klok, Anton Vonk Noordegraaf, Petr Symersky, Harm-Jan Bogaard, Lilian J. Meijboom   +10 more
doaj   +1 more source

Case report: Central venous catheter thrombosis complicated by chronic thromboembolic disease/pulmonary hypertension in two children requiring parenteral nutrition

Frontiers in Cardiovascular Medicine, 2023
Chronic thromboembolic pulmonary hypertension is a rare but life-threatening complication of long-term central venous catheters (CVC) in children. However, evidence in terms of potential treatment strategies and outcome data remains scarce.
Maja Hanuna, Joseph Pattathu, Joscha Buech, Joscha Buech, Christine Kamla, Nikolaus Kneidinger, Nikolaus Kneidinger, Juergen Behr, Juergen Behr, Katrin Milger, Katrin Milger, Tobias Veit, Tobias Veit, Marina Nagel, Jan Abicht, Robert Dalla-Pozza, Marcus Fischer, Andre Jakob, Matthias Hermann, Rene Schramm, Laura L. Rosenthal, Nikolaus Haas, Jürgen Hörer, Jürgen Hörer, Christian Hagl, Christian Hagl, Christian Hagl, Sebastian G. Michel, Sebastian G. Michel, Sebastian G. Michel, Sebastian G. Michel, Sebastian G. Michel   +31 more
doaj   +1 more source

Altered gut microbiota and its association with inflammation in patients with chronic thromboembolic pulmonary hypertension: a single-center observational study in Japan

BMC Pulmonary Medicine, 2022
Background The pathogenesis of chronic thromboembolic pulmonary hypertension (CTEPH) is considered to be associated with chronic inflammation; however, the underlying mechanism remains unclear. Recently, altered gut microbiota were found in patients with
Yumiko Ikubo, T. Sanada, Koji Hosomi, Jonguk Park, A. Naito, Hiroki Shoji, T. Misawa, Rika Suda, Ayumi Sekine, T. Sugiura, A. Shigeta, H. Nanri, S. Sakao, N. Tanabe, K. Mizuguchi, J. Kunisawa, Takuji Suzuki, K. Tatsumi   +17 more
semanticscholar   +1 more source

Under pressure: pulmonary hypertension associated with left heart disease. [PDF]

, 2015
© ERS 2015.Pulmonary hypertension (PH) associated with left heart disease (PH-LHD) is the most common type of PH, but its natural history is not well understood.
Farber, HW, Gibbs, S
core   +2 more sources

Direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension and the presence of recent thrombus during pulmonary endarterectomy

Pulmonary Circulation, 2022
Patients with chronic thromboembolic pulmonary hypertension (CTEPH) require lifelong anticoagulant therapy. The safety and efficacy of direct oral anticoagulant (DOAC) in the chronic and transitional management of CTEPH has not been investigated.
Ina Jeong, M. Alotaibi, T. Fernandes, Suhyun Kim, K. Kerr, Jenny Z. Yang, V. Pretorius, M. Madani, Nick H. Kim   +8 more
semanticscholar   +1 more source

Chronic Thromboembolic Disease and Chronic Thromboembolic Pulmonary Hypertension

Clinics in Chest Medicine, 2021
Chronic thromboembolic pulmonary hypertension (CTEPH) and chronic thromboembolic pulmonary vascular disease (CTED) are rare manifestations of venous thromboembolism. Presumably, CTEPH and CTED are variants of the same pathophysiological mechanism. CTEPH and CTED can be near-cured by pulmonary endarterectomy, balloon pulmonary angioplasty, and medical ...
Irene M, Lang, Ioana A, Campean, Roela, Sadushi-Kolici, Roza, Badr-Eslam, Christian, Gerges, Nika, Skoro-Sajer   +5 more
openaire   +2 more sources

Chronic Embolic Pulmonary Hypertension Caused by Pulmonary Embolism and Vascular Endothelial Growth Factor Inhibition [PDF]

, 2017
Our understanding of the pathophysiological basis of chronic thromboembolic pulmonary hypertension (CTEPH) will be accelerated by an animal model that replicates the phenotype of human CTEPH.
Brown, Mary B., Goodwill, Adam G., Kline, Jeffrey A., McCarthy, Brian P., Neto-Neves, Evandro M., Persohn, Scott A., Rezania, Samin, Territo, Paul R., Zaretskaia, Maria V.   +8 more
core   +1 more source

A CASE REPORT OF CHRONIC PULMONARY THROMBOEMBOLISM AND ACCOMPANYING CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION: CHRONIC PULMONARY THROMBOEMBOLISM AND HYPERTENSION

Acta Medica Leopoliensia, 2022
Aim. Our paper aims to discuss the radiological and clinical findings of chronic pulmonary embolism (CPTE) and chronic thromboembolic pulmonary hypertension (CTEPH) over the patient's findings. Material and Methods. We present the case of a 49-year-old female patient with CPTE and CTEPH. Results and Discussion.
Emrah Dogan, Ozge Oral Tapan, Utku Tapan, Sabri Serhan Olcay   +3 more
openaire   +2 more sources